Tracking early ageing signs in young adults with cancer
Blood samples are taken from young adults with cancer before and one year into treatment.
Plain-language title generated from the registry record
Registry title: Early Ageing During Therapy in AYA Cancer Patients
Key facts
- Where
- Groningen, NetherlandsSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 39 years old?
Source: NCT05062707, who can take part
Where in Netherlands
- University Medical Center GroningenGroningen, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Medical Center Groningen
- Trial code
- NCT05062707
- Record updated
- 13 May 2025
- Original description
Longitudinal cohort study; measurements before start of systemic therapy and one year later.Read full original descriptionShow less
Longitudinal Assessment of Therapy-related Early Ageing in Adolescent and Young Adult (AYA) Cancer Patients
Longitudinal cohort study; measurements before start of systemic therapy and one year later.
Inclusion: Aged 18-39 years at cancer diagnosis; Having a histologically and/or cytologically confirmed cancer diagnosis, including leukemia, (non-)Hodgkin lymphoma, testicular cancer, osteosarcoma, Ewing sarcoma, breast cancer, and cervical cancer; Scheduled to start systemic therapy with curative intent. Allowed treatments (concurrent or sequential) are: surgery, radiotherapy, chemotherapy, antibodies.
Exclusion: patients who will be treated with immune checkpoint inhibitors or targeted therapy with inhibitors of angiogenesis; patients who have been treated with systemic therapy or radiotherapy for a previous malignancy (exceptions: in situ carcinoma of the cervix or uterus and adequately treated basal and squamous cell carcinoma of the skin); patients who are not able to understand the patient information letter and informed consent form.